Eurofins Scientific SE

ERF: XPAR (FRA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
lh^LOCK|CjDvPLOCK|<gc@XF

Eurofins Trading Update: Temporary Operational Headwinds Weigh on Full-Year Sales

Eurofins Scientific’s organic sales growth was 3.5% in the third quarter, showing a gradual acceleration over the last nine months. Shares were trading about 2% higher intraday on Oct. 21.

Sponsor Center